Co-Diagnostics Sees Class Action Lawsuit Dismissed
Co-Diagnostics successfully won the complete dismissal of a securities class action lawsuit on March 4, 2025.
Read MorePosted by Chris Wolski | Mar 7, 2025 | Company News |
Co-Diagnostics successfully won the complete dismissal of a securities class action lawsuit on March 4, 2025.
Read MorePosted by Chris Wolski | Mar 5, 2025 | Gastrointestinal Infections |
A new study suggests that people with Crohn’s disease and joint inflammation have distinct gut microbiota, pointing to a possible biomarker.
Read MorePosted by Chris Wolski | Mar 4, 2025 | Infectious Diseases |
Smartwatches can detect infections before symptoms appear. Following a watch’s advice to isolate, could reduce disease transmission.
Read MorePosted by Chris Wolski | Feb 21, 2025 | Covid 19 |
Co-Diagnostics has withdrawn its 510(k) application for its Co-Dx PCR COVID-19 Test in favor of submitting an enhanced version.
Read MorePosted by Chris Wolski | Feb 18, 2025 | Covid 19 |
Hologic, Inc. has received FDA 510(k) clearance for its Aptima SARS-CoV-2 assay, initially authorized for emergency use in 2020.
Read More